|
6567a383212eaade2e0f1754
|
2020
|
Germany
|
Foreign Office
|
2020009279
|
6614392
|
8
|
Serbia
|
Europe
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.022791
|
0.022791
|
0
|
0
|
0.022791
|
0.022791
|
|
0.022791
|
|
0
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
PORTABLE PULSE OXIMETERS AND O...XYGEN THERAPY ITEMS, SENSORS, AIR ADAPTERS AND CANNULAS FOR THE CLINIC FOR ANESTHESIA AND INTENSIVE CARE OF THE CLINICAL
more
|
portable pulse oximeters and o...xygen therapy items, sensors, air adapters and cannulas for the Clinic for Anesthesia and Intensive Care of the Clinical
more
|
The project is aimed at end-st...age COVID-19 patients with severe breathing problems. These patients are in the critical phase of the disease and the main problem is the critical gas exchange in the lungs. The project addresses these patients as the equipment required will improve treatment and increase the number of patients. The listed products were specifically named by the team of the anaesthesia and intensive care clinic in Niš as particularly important and urgently necessary. The aim is to improve the number and quality of care for patients who were cared for during the COVID-19 emergency in the anaesthesia and intensive care clinic in Niš.
more
|
|
12264
|
COVID-19 control
|
|
I.2.b. Basic Health
|
11001
|
Central Government
|
Foreign Office
|
|
COVID-19
|
|
6567a383212eaade2e0f1755
|
2020
|
Germany
|
Foreign Office
|
2020009545
|
6614942
|
8
|
Serbia
|
Europe
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.072787
|
0.072787
|
0
|
0
|
0.072787
|
0.072787
|
|
0.072787
|
|
0
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
EQUIPPING GENERAL HOSPITAL ŠA...BAC WITH DIGITAL MOBILE RADIOGRAPHIC/X-RAY-MACHINE FOR DIAGNOSIS AND TREATMENT OF COVID-19 PATIENTS
more
|
Equipping General Hospital Ša...bac with Digital Mobile Radiographic/X-ray-Machine for diagnosis and treatment of Covid-19 patients
more
|
The infection situation in Ser...bia has worsened in the last few months, accordingly the Šabac hospital has been converted into a COVID clinic. The clinic covers a large part of the surrounding communities and cities (approx. 300,000 inhabitants) and treats other serious cases in addition to COVID patients. In view of the hospital's pavilion type (patients are in different buildings) and the growing number of examined and hospitalized patients, the procurement of a mobile X-ray machine was identified as particularly important. A portable x-ray machine could enable rapid radiological diagnosis of patients with COVID-19 (many of whom have severe symptoms - patients confined to bed and immobile patients in intensive care units) and thus timely decisions about appropriate therapy and other options for treatment exhibit.
more
|
|
12264
|
COVID-19 control
|
|
I.2.b. Basic Health
|
11001
|
Central Government
|
Foreign Office
|
|
COVID-19
|
|
6567a384212eaade2e0f1756
|
2020
|
Germany
|
Foreign Office
|
2020009437
|
6614701
|
8
|
Ukraine
|
Europe
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.016888
|
0.016888
|
0
|
0
|
0.016888
|
0.016888
|
|
0.016888
|
|
0
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
COVID-19 - MEDICAL BEDS AND EQ...UIPMENT FOR THE DISTRICT INFECTIOUS DISEASES HOSPITAL IN STAROBILSK, IN THE CONFLICT-AFFECTED DONBAS, UKRAINE
more
|
COVID-19 - Medical beds and eq...uipment for the district infectious diseases hospital in Starobilsk, in the conflict-affected Donbas, Ukraine
more
|
This Project is one of the mic...ro-projects of the Consulate General Donetsk in its consular district (5 regions of the Eastern Ukraine). This part of the country needs a special support, because of the war in the Donbas, the constant migration of internally displaced persons and the insufficient state support for people in need. The COVID-19 pandemic aggravated the situation in the Donbas. Despite the lack of equipment, the Starobilsk hospital has become one of the most important hospitals for the treatment of COVID patients in the Luhansk region. But the hospital's capabilities allow treating only 30 patients at the same time. And the beds used were produced more than 40 years ago. Thanks to the project 15 additional beds and other medical equipment (4 medical monitors, 3 electrocardiographs) have been purchased, which significantly improve the treatment conditions in the hospital.
more
|
|
12264
|
COVID-19 control
|
|
I.2.b. Basic Health
|
12004
|
Other public entities in recip...ient country
more
|
Other public entities in recip...ient country
more
|
|
COVID-19
|
|
6567a384212eaade2e0f1757
|
2020
|
Italy
|
Local administration
|
2020085087
|
87/20
|
1
|
Ethiopia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.00110121
|
0
|
0
|
0
|
0.003337
|
|
|
|
0.003337
|
|
COVID-19
|
COVID-19 Personal Protective E...quipment
more
|
33
|
COVID-19 EMERGENCY PROJECT IN ...ALEMTENA, CHOLE AND WARAGU (ETHIOPIA)
more
|
Covid-19 emergency project in ...Alemtena, Chole and Waragu (Ethiopia)
more
|
Provision of medicines, protec...tive materials and food supplements, as well as food packages for 100 particularly needy families in the context of covid-19 pandemic.
more
|
|
72010
|
Material relief assistance and... services
more
|
3,2
|
VIII.1. Emergency Response
|
22000
|
Donor country-based NGO
|
Caritas Diocesi Bolzano-Bressa...none
more
|
|
COVID-19
|
|
6567a384212eaade2e0f1758
|
2020
|
Italy
|
Local administration
|
2020085088
|
88/20
|
1
|
Kenya
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.004879
|
0
|
0
|
0
|
0.004879
|
|
|
|
0.004879
|
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
EXTRAORDINARY SUPPLY OF TECHNI...CAL MEDICAL EQUIPMENT FOR THE ST. ELIZABETH MISSION HOSPITAL IN MUKUMU - KENYA (COVIC-19 EMERGENCY)
more
|
Extraordinary supply of techni...cal medical equipment for the St. Elizabeth Mission Hospital in Mukumu - Kenya (Covic-19 emergency)
more
|
Purchase of materials and equi...pment to fight covid-19 pandemic, in order to improve the quality of the medical assistance and raising the life-expectancy of the patients affected by the pandemic virus.
more
|
|
12264
|
COVID-19 control
|
3
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
CIRCLE Association for Interna...tional Cooperation & Development onlus
more
|
|
COVID-19
|
|
6567a384212eaade2e0f1759
|
2020
|
Italy
|
Central administration
|
2020070034
|
KOS/RC-W/2020/A/5/12/ABS/
|
1
|
Kosovo
|
Europe
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.016507
|
0.016507
|
0
|
0
|
0.016507
|
0.016507
|
|
0.016507
|
|
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
REPAIR AND MAINTENANCE OF THE ...HOSPITAL OXYGEN PRODUCTION PLANT
more
|
Repair and maintenance of the ...Hospital oxygen production plant
more
|
Repair and maintenance of the ...medical oxygen production plant of the Hospital Prim. Dr.Daut Mustafa Hospital, in the context of covid-19 pandemic.
more
|
|
12264
|
COVID-19 control
|
3.c,3.8
|
I.2.b. Basic Health
|
11001
|
Central Government
|
MINISTERO DIFESA
|
|
COVID-19
|
|
6567a385212eaade2e0f175a
|
2020
|
Italy
|
Central administration
|
2020070075
|
LEB/JTF-L/2020/A/5/16/ABS/
|
1
|
Lebanon
|
Middle East
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.00597
|
0.00597
|
0
|
0
|
0.00597
|
0.00597
|
|
0.00597
|
|
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
PROVISION OF A VIDEO-LARYNGOSC...OPY INSTRUMENT
more
|
Provision of a Video-Laryngosc...opy instrument
more
|
Provision of a Video-Laryngosc...opy instrument for the Public Hospital of Bint Jbeil, in the context of covid-19 pandemic.
more
|
|
12264
|
COVID-19 control
|
3.d
|
I.2.b. Basic Health
|
11001
|
Central Government
|
MINISTERO DIFESA
|
|
COVID-19
|
|
6567a385212eaade2e0f175b
|
2020
|
Italy
|
Central administration
|
2020070065
|
LEB/JTF-L/2020/A/5/7/ABS/
|
1
|
Lebanon
|
Middle East
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.080707
|
0.080707
|
0
|
0
|
0.080707
|
0.080707
|
|
0.080707
|
|
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
PROVISION OF RESPIRATORS
|
Provision of respirators
|
Provision of respirators to co...pe with the Covid-19 emergency
more
|
|
12264
|
COVID-19 control
|
3.d
|
I.2.b. Basic Health
|
11001
|
Central Government
|
MINISTERO DIFESA
|
|
COVID-19
|
|
6567a385212eaade2e0f175c
|
2020
|
Japan
|
Ministry of Foreign Affairs
|
2020050853
|
|
8
|
Middle East, regional
|
Middle East
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0.30000003
|
0.30000003
|
0
|
0
|
0.909091
|
0.909091
|
|
0.909091
|
|
|
COVID-19
|
COVID-19 Therapeutics
|
33
|
GENDER-RESPONSIVE MANAGEMENT A...ND RESPONSE TO THE COVID-19 PANDEMIC IN THE ARAB STATES REGION: FROM EMERGENCY RESPONSE TO RECOVERY AND RESILIENCE
more
|
Gender-responsive Management a...nd Response to the COVID-19 Pandemic in the Arab States Region: From Emergency Response to Recovery and Resilience
more
|
Provide gender-responsive care... for the COVID-19, support for women's livehood maintainance, and encourage women's economic empowerment
more
|
|
15170
|
Women's rights organisations a...nd movements, and government institutions
more
|
5
|
I.5.a. Government & Civil Soci...ety-general
more
|
41146
|
United Nations Entity for Gend...er Equality and the Empowerment of Women
more
|
United Nations Entity for Gend...er Equality and the Empowerment of Women
more
|
|
COVID-19
|
|
6567a386212eaade2e0f175d
|
2020
|
Spain
|
Public Universities
|
2020001316-1
|
009-136462-A
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D01
|
0.009117
|
0.009117
|
0
|
0
|
0.009117
|
0.009117
|
0
|
0
|
0
|
0.009117
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
INTERNAL CALL PROJECT DESIGN A...ND DEVELOPMENT OF SANITARY PPE DIGITALLY MANUFACTURED AND 3D PRINTED FOR THEIR FREE DISTRIBUTION
more
|
INTERNAL CALL PROJECT Design a...nd development of sanitary PPE digitally manufactured and 3d printed for their free distribution
more
|
Desarrollo de EPIs para profes...ionales sanitarios, prototipaje de respiradores de apoyo a ventilación no invasiva y otras herramientas de apoyo centradas en soluciones para la pandemia actual, con el objetivo de escalar las soluciones a los países que más lo necesiten. S'ha activat la compatibilitat amb el lector de pantalla.
more
|
|
12182
|
Medical research
|
3.D
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Politechnic University of Cata...lonia.
more
|
|
|
|
6567a386212eaade2e0f175e
|
2020
|
Spain
|
Public Universities
|
2020001317-1
|
009-136463-A
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D01
|
0.006838
|
0.006838
|
0
|
0
|
0.006838
|
0.006838
|
0
|
0
|
0
|
0.006838
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
INTERNAL CALL PROJECT UPC MANR...ESA
more
|
INTERNAL CALL PROJECT UPC Manr...esa
more
|
Desarrollo del diseño de un v...entilador (respirador) de bajo costo (objetivo de 750 €) replicable alrededor del mundo para hacer frente a necesidades de curas intensivas en zonas con infraestructura médica mínima. Se trata de un diseño con hardware abierto, especificaciones mecánicas abiertas, componentes de bajo coste y fácilmente suministrables, acompañado de software libre y abierto.
more
|
|
12182
|
Medical research
|
3.D
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Politechnic University of Cata...lonia.
more
|
|
|
|
6567a386212eaade2e0f175f
|
2020
|
Spain
|
Ministry of Foreign Affairs an...d Co-operation
more
|
2020001906-1
|
009-137062-A
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0.42735
|
0.42735
|
0
|
0
|
0.42735
|
0.42735
|
0
|
0.42735
|
0
|
0
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
CONTRIBUTION TO UNITAID - COVI...D-19
more
|
Contribution to UNITAID - COVI...D-19
more
|
Contribución a UNITAID - COVI...D-19
more
|
|
12264
|
COVID-19 control
|
3.B
|
I.2.b. Basic Health
|
30010
|
International drug purchase fa...cility
more
|
International drug purchase fa...cility
more
|
|
|
|
6567a386212eaade2e0f1760
|
2020
|
Spain
|
Public Universities
|
2020001321-1
|
009-136467-A
|
1
|
Ecuador
|
South America
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
D01
|
0.011817
|
0.011817
|
0
|
0
|
0.011817
|
0.011817
|
0
|
0
|
0
|
0.011817
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
INTERNAL CALL PROJECT DESIGN A...UTOMATION AND MANUFACTURING OF AN ADEQUATE ACTUATOR FOR MANUAL RESPIRATORS
more
|
INTERNAL CALL PROJECT Design a...utomation and manufacturing of an adequate actuator for manual respirators
more
|
Diseño y automatización de u...n actuador para respiradores manuales . La finalidad es hacerlos servir sin intervención de personal sanitario. La propuesta consiste en adaptar este diseño al contexto tecnológico , de fabricación y económico de Ecuador para cubrir sus necesidades. Los respiradores automáticos son escasos en la sanidad pública ecuatoriana, es más frecuente que hay respiradores manuales. Con este mecanismo es posible hacerlos útiles sin que actúe una persona. Con un diseño seria sencillo y económico que se podría fabricar allí, dando también oportunidades a talleres locales, a más de ser extensible a otros países.
more
|
|
12182
|
Medical research
|
3.D
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Politechnic University of Cata...lonia.
more
|
|
|
|
6567a386212eaade2e0f1761
|
2020
|
Switzerland
|
Swiss Agency for Development a...nd Co-operation
more
|
2020009308
|
7F-10051.02.03
|
3
|
America, regional
|
America
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.026624
|
0.0238
|
0
|
0
|
0.026624
|
0.0238
|
|
0.026624
|
|
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
RR COVID 19 PRE-HOSPITALCARE&F...SINECUADOR - SMALL ACTION CREDIT
more
|
RR Covid 19 Pre-HospitalCare&F...SinEcuador - small action credit
more
|
Les crédits globaux pour peti...tes actions permettent le financement d'opérations ponctuelles, peu coûteuses, significatives en termes de développement, à composantes diverses (techniques, sociales, organisationnelles et de gestion, politique, économique, informative, etc.)
more
|
|
72050
|
Relief co-ordination and suppo...rt services
more
|
5,16,1.5
|
VIII.1. Emergency Response
|
21018
|
International Federation of Re...d Cross and Red Crescent Societies
more
|
|
|
COVID-19
|
|
6567a387212eaade2e0f1762
|
2020
|
Switzerland
|
Swiss Agency for Development a...nd Co-operation
more
|
2020008972
|
7F-07700.03.09
|
3
|
Kyrgyzstan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.001757
|
0.00175
|
0
|
0
|
0.001757
|
0.00175
|
|
0.001757
|
|
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
KGZ:COVID19 DON.OF 2 OXYGEN CO...NCENTRATOR - SMALL ACTION CREDIT
more
|
KGZ:COVID19 Don.of 2 Oxygen Co...ncentrator - small action credit
more
|
Les crédits globaux pour peti...tes actions permettent le financement d'opérations ponctuelles, peu coûteuses, significatives en termes de développement, à composantes diverses (techniques, sociales, organisationnelles et de gestion, politique, économique, informative, etc.)
more
|
|
12250
|
Infectious disease control
|
3.8,3.3
|
I.2.b. Basic Health
|
11001
|
Central Government
|
Corps suisse d'aide humanitair...e
more
|
|
COVID-19
|
|
6567a388212eaade2e0f1763
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020022444A
|
76_64282
|
1
|
Bolivia
|
South America
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.201604
|
0.2
|
0
|
0
|
0.201604
|
0.2
|
0
|
0.201604
|
|
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
COVID-19 ASSISTANCE
|
COVID-19 Assistance
|
Support assessments and techni...cal assistance for the use of COVID-19 ventilators.
more
|
|
12264
|
COVID-19 control
|
COVID-19
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
PROSALUD
|
|
|
|
6567a388212eaade2e0f1764
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020022444B
|
76_64282
|
1
|
Bolivia
|
South America
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.598396
|
0
|
0
|
0
|
0.598396
|
0
|
0
|
0.598396
|
|
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
COVID-19 ASSISTANCE
|
COVID-19 Assistance
|
Support assessments and techni...cal assistance for the use of COVID-19 ventilators.
more
|
|
12264
|
COVID-19 control
|
COVID-19
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
PROSALUD
|
|
|
|
6567a388212eaade2e0f1765
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020023439
|
76_65296
|
1
|
Ecuador
|
South America
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.5
|
0.25
|
0
|
0
|
0.5
|
0.25
|
0
|
0.5
|
|
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
RESPOND TO THE CRITICAL NEED F...OR OXYGEN ECOSYSTEMS IN ECUADOR AMID THE ONGOING COVID-19 CRISIS.
more
|
Respond To The Critical Need F...or Oxygen Ecosystems In Ecuador Amid The Ongoing COVID-19 Crisis.
more
|
Respond To The Critical Need F...or Oxygen Ecosystems In Ecuador Amid The Ongoing COVID-19 Crisis.
more
|
|
12264
|
COVID-19 control
|
COVID-19
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - Non United States Other
|
|
|
|
6567a388212eaade2e0f1766
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020022466
|
76_64300
|
1
|
South Sudan
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
6.2283
|
2.952374
|
0
|
0
|
6.2283
|
2.952374
|
0
|
6.2283
|
|
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
COVID-19 RESPONSE IN SOUTH SUD...AN THROUGH CASE MANAGEMENT AND TRIAGE IN JUBA, MALAKAL, AND WAU
more
|
COVID-19 Response In South Sud...an Through Case Management And Triage In Juba, Malakal, And Wau
more
|
COVID-19 Response In S.Sudan T...hrough Case Management And Triage In Juba, Malakal, And Wau
more
|
|
12264
|
COVID-19 control
|
COVID-19
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
International Medical Corps
|
|
|
|
6567a388212eaade2e0f1767
|
2020
|
Austria
|
Federal Ministry of Finance
|
2020018016
|
AsEB-19-P
|
8
|
Asia, regional
|
Asia
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0.5698005
|
0.5698005
|
0
|
0
|
1.139601
|
1.139601
|
0
|
1.139601
|
|
0
|
COVID-19
|
COVID-19 Diagnostics
|
50
|
COFINANCING AGREEMENT FOR ACCE...LERATING SANITATION FOR ALL IN ASIA AND THE PACIFIC
more
|
Cofinancing Agreement for Acce...lerating Sanitation for All in Asia and the Pacific
more
|
Co-financing of technical assi...stance of the AsDB in the area of diagnostics of transmittable diseases (i.e. COVID-19) via wastewater and strengthening of asset management in water and sanitation utilities, including in the context of climate change-induced weather events (i.e. flooding).
more
|
|
14020
|
Water supply and sanitation - ...large systems
more
|
6,3,11
|
I.4. Water Supply & Sanitation
|
46004
|
Asian Development Bank
|
AsDB
|
|
COVID-19
|
|
6567a389212eaade2e0f1768
|
2020
|
Canada
|
Global Affairs Canada
|
20202003430003
|
P009105001
|
1
|
Africa, regional
|
Africa
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0.892611
|
0.892611
|
0
|
0
|
0.892611
|
0.892611
|
0
|
0.892611
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
IAEA ASSISTANCE IN INTERNATION...AL COVID-19 RESPONSE/ASSISTANCE A L'AIEA DANS LA RÉPONSE INTERNATIONALE AU COVID-19
more
|
IAEA Assistance in Internation...al COVID-19 Response/Assistance a l'AIEA dans la réponse internationale au COVID-19
more
|
The International Atomic Energ...y Agency (IAEA) will provide diagnostic kits, equipment and training in nuclear-derived detection techniques to countries asking for assistance in tackling the worldwide spread of the novel coronavirus causing COVID-19. The assistance, requested by over 65 countries in Africa, Asia, Latin America and the Caribbean, and Eastern Europe and the Caucasus, is part of intensified global efforts to contain infections. The diagnostic technique, known as real time reverse transcription–polymerase chain reaction (real time RT-PCR), can help detect and identify the novel coronavirus accurately within hours in humans, as well as in animals that may also host it. The IAEA is a member of the World Health Organization (WHO) COVID-19 crisis management team, because the equipment required for this RT-PCR diagnostic procedure relies on nuclear techniques, the IAEA is taking the lead in procuring and delivering these toolkits to requesting countries.
more
|
|
12264
|
COVID-19 control
|
3
|
I.2.b. Basic Health
|
41107
|
International Atomic Energy Ag...ency (Contributions to Technical Cooperation Fund Only)
more
|
International Atomic Energy Ag...encyNuclear Security Fund
more
|
|
COVID-19
|
|
6567a389212eaade2e0f1769
|
2020
|
Canada
|
Global Affairs Canada
|
20202003430002
|
P009105001
|
1
|
Africa, regional
|
Africa
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0.449471
|
0.449471
|
0
|
0
|
0.449471
|
0.449471
|
0
|
0.449471
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
IAEA ASSISTANCE IN INTERNATION...AL COVID-19 RESPONSE/ASSISTANCE A L'AIEA DANS LA RÉPONSE INTERNATIONALE AU COVID-19
more
|
IAEA Assistance in Internation...al COVID-19 Response/Assistance a l'AIEA dans la réponse internationale au COVID-19
more
|
The International Atomic Energ...y Agency (IAEA) will provide diagnostic kits, equipment and training in nuclear-derived detection techniques to countries asking for assistance in tackling the worldwide spread of the novel coronavirus causing COVID-19. The assistance, requested by over 65 countries in Africa, Asia, Latin America and the Caribbean, and Eastern Europe and the Caucasus, is part of intensified global efforts to contain infections. The diagnostic technique, known as real time reverse transcription–polymerase chain reaction (real time RT-PCR), can help detect and identify the novel coronavirus accurately within hours in humans, as well as in animals that may also host it. The IAEA is a member of the World Health Organization (WHO) COVID-19 crisis management team, because the equipment required for this RT-PCR diagnostic procedure relies on nuclear techniques, the IAEA is taking the lead in procuring and delivering these toolkits to requesting countries.
more
|
|
12264
|
COVID-19 control
|
3
|
I.2.b. Basic Health
|
41107
|
International Atomic Energy Ag...ency (Contributions to Technical Cooperation Fund Only)
more
|
International Atomic Energy Ag...encyNuclear Security Fund
more
|
|
COVID-19
|
|
6567a389212eaade2e0f176a
|
2020
|
Canada
|
Global Affairs Canada
|
20202007190002
|
P009517001
|
3
|
Africa, regional
|
Africa
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
1.06392
|
0
|
0
|
0
|
1.06392
|
0
|
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
SUPPORT FOR AFRICA-CDC PARTNER...SHIP TO ACCELERATE COVID-19 TESTING/SOUTIEN AU PARTENARIAT DES CDC AFRICAINS POUR ACCÉLÉRER LES ESSAIS DE COVID-19
more
|
Support for Africa-CDC Partner...ship to accelerate COVID-19 testing/Soutien au partenariat des CDC africains pour accélérer les essais de COVID-19
more
|
This project contributes to th...e implementation of the Africa Joint Continental Strategy for Covid-19 outbreak, led by the Africa Centres for Disease Control & Prevention (A-CDC). Specifically, this project supports the African Society for Laboratory Medicine (ASLM) for the implementation of the Africa CDC's Partnership to accelerate COVID-19 testing initiative to : 1) procure and distribute test kits and supplies, 2) assist national public health laboratories to build the capacity for COVID 19 testing at the sub-national level and 3) assess sub-national level laboratories to guide corrective action and improve the quality of COVID-19 testing. / Ce projet contribue à la mise en œuvre de la Stratégie continentale commune africaine pour l'épidémie de Covid-19, dirigée par les Centres africains de contrôle et de prévention des maladies (A-CDC). Plus précisément, ce projet soutient la Société africaine de médecine de laboratoire (ASLM) pour la mise en œuvre du partenariat des CDC africains visant à accélérer l'initiative de test COVID-19 pour : 1) acheter et distribuer des kits et fournitures de test, 2) aider les laboratoires nationaux de santé publique à renforcer les capacités des laboratoires sous-nationaux pour tester le COVID-19 et 3) évaluer les laboratoires au niveau sous-national pour guider les mesures correctives et améliorer la qualité des tests du COVID-19.
more
|
|
12264
|
COVID-19 control
|
3
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
African Society Laboratory Med...icine
more
|
|
COVID-19
|
|
6567a389212eaade2e0f176b
|
2020
|
Canada
|
Global Affairs Canada
|
20202007190001
|
P009517001
|
3
|
Africa, regional
|
Africa
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.535737
|
0
|
0
|
0
|
0.535737
|
0
|
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
SUPPORT FOR AFRICA-CDC PARTNER...SHIP TO ACCELERATE COVID-19 TESTING/SOUTIEN AU PARTENARIAT DES CDC AFRICAINS POUR ACCÉLÉRER LES ESSAIS DE COVID-19
more
|
Support for Africa-CDC Partner...ship to accelerate COVID-19 testing/Soutien au partenariat des CDC africains pour accélérer les essais de COVID-19
more
|
This project contributes to th...e implementation of the Africa Joint Continental Strategy for Covid-19 outbreak, led by the Africa Centres for Disease Control & Prevention (A-CDC). Specifically, this project supports the African Society for Laboratory Medicine (ASLM) for the implementation of the Africa CDC's Partnership to accelerate COVID-19 testing initiative to : 1) procure and distribute test kits and supplies, 2) assist national public health laboratories to build the capacity for COVID 19 testing at the sub-national level and 3) assess sub-national level laboratories to guide corrective action and improve the quality of COVID-19 testing. / Ce projet contribue à la mise en œuvre de la Stratégie continentale commune africaine pour l'épidémie de Covid-19, dirigée par les Centres africains de contrôle et de prévention des maladies (A-CDC). Plus précisément, ce projet soutient la Société africaine de médecine de laboratoire (ASLM) pour la mise en œuvre du partenariat des CDC africains visant à accélérer l'initiative de test COVID-19 pour : 1) acheter et distribuer des kits et fournitures de test, 2) aider les laboratoires nationaux de santé publique à renforcer les capacités des laboratoires sous-nationaux pour tester le COVID-19 et 3) évaluer les laboratoires au niveau sous-national pour guider les mesures correctives et améliorer la qualité des tests du COVID-19.
more
|
|
12264
|
COVID-19 control
|
3
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
African Society Laboratory Med...icine
more
|
|
COVID-19
|
|
6567a389212eaade2e0f176c
|
2020
|
Canada
|
Global Affairs Canada
|
20202003430004
|
P009105001
|
1
|
America, regional
|
America
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
1.020094
|
1.020094
|
0
|
0
|
1.020094
|
1.020094
|
0
|
1.020094
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
IAEA ASSISTANCE IN INTERNATION...AL COVID-19 RESPONSE/ASSISTANCE A L'AIEA DANS LA RÉPONSE INTERNATIONALE AU COVID-19
more
|
IAEA Assistance in Internation...al COVID-19 Response/Assistance a l'AIEA dans la réponse internationale au COVID-19
more
|
The International Atomic Energ...y Agency (IAEA) will provide diagnostic kits, equipment and training in nuclear-derived detection techniques to countries asking for assistance in tackling the worldwide spread of the novel coronavirus causing COVID-19. The assistance, requested by over 65 countries in Africa, Asia, Latin America and the Caribbean, and Eastern Europe and the Caucasus, is part of intensified global efforts to contain infections. The diagnostic technique, known as real time reverse transcription–polymerase chain reaction (real time RT-PCR), can help detect and identify the novel coronavirus accurately within hours in humans, as well as in animals that may also host it. The IAEA is a member of the World Health Organization (WHO) COVID-19 crisis management team, because the equipment required for this RT-PCR diagnostic procedure relies on nuclear techniques, the IAEA is taking the lead in procuring and delivering these toolkits to requesting countries.
more
|
|
12264
|
COVID-19 control
|
3
|
I.2.b. Basic Health
|
41107
|
International Atomic Energy Ag...ency (Contributions to Technical Cooperation Fund Only)
more
|
International Atomic Energy Ag...encyNuclear Security Fund
more
|
|
COVID-19
|
|
6567a38a212eaade2e0f176d
|
2020
|
Canada
|
Global Affairs Canada
|
20202003430005
|
P009105001
|
1
|
America, regional
|
America
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0.061027
|
0.061027
|
0
|
0
|
0.061027
|
0.061027
|
0
|
0.061027
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
IAEA ASSISTANCE IN INTERNATION...AL COVID-19 RESPONSE/ASSISTANCE A L'AIEA DANS LA RÉPONSE INTERNATIONALE AU COVID-19
more
|
IAEA Assistance in Internation...al COVID-19 Response/Assistance a l'AIEA dans la réponse internationale au COVID-19
more
|
The International Atomic Energ...y Agency (IAEA) will provide diagnostic kits, equipment and training in nuclear-derived detection techniques to countries asking for assistance in tackling the worldwide spread of the novel coronavirus causing COVID-19. The assistance, requested by over 65 countries in Africa, Asia, Latin America and the Caribbean, and Eastern Europe and the Caucasus, is part of intensified global efforts to contain infections. The diagnostic technique, known as real time reverse transcription–polymerase chain reaction (real time RT-PCR), can help detect and identify the novel coronavirus accurately within hours in humans, as well as in animals that may also host it. The IAEA is a member of the World Health Organization (WHO) COVID-19 crisis management team, because the equipment required for this RT-PCR diagnostic procedure relies on nuclear techniques, the IAEA is taking the lead in procuring and delivering these toolkits to requesting countries.
more
|
|
12264
|
COVID-19 control
|
3
|
I.2.b. Basic Health
|
41107
|
International Atomic Energy Ag...ency (Contributions to Technical Cooperation Fund Only)
more
|
International Atomic Energy Ag...encyNuclear Security Fund
more
|
|
COVID-19
|
|
6567a38a212eaade2e0f176e
|
2020
|
Canada
|
Global Affairs Canada
|
20202003430006
|
P009105001
|
1
|
Asia, regional
|
Asia
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0.681211
|
0.681211
|
0
|
0
|
0.681211
|
0.681211
|
0
|
0.681211
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
IAEA ASSISTANCE IN INTERNATION...AL COVID-19 RESPONSE/ASSISTANCE A L'AIEA DANS LA RÉPONSE INTERNATIONALE AU COVID-19
more
|
IAEA Assistance in Internation...al COVID-19 Response/Assistance a l'AIEA dans la réponse internationale au COVID-19
more
|
The International Atomic Energ...y Agency (IAEA) will provide diagnostic kits, equipment and training in nuclear-derived detection techniques to countries asking for assistance in tackling the worldwide spread of the novel coronavirus causing COVID-19. The assistance, requested by over 65 countries in Africa, Asia, Latin America and the Caribbean, and Eastern Europe and the Caucasus, is part of intensified global efforts to contain infections. The diagnostic technique, known as real time reverse transcription–polymerase chain reaction (real time RT-PCR), can help detect and identify the novel coronavirus accurately within hours in humans, as well as in animals that may also host it. The IAEA is a member of the World Health Organization (WHO) COVID-19 crisis management team, because the equipment required for this RT-PCR diagnostic procedure relies on nuclear techniques, the IAEA is taking the lead in procuring and delivering these toolkits to requesting countries.
more
|
|
12264
|
COVID-19 control
|
3
|
I.2.b. Basic Health
|
41107
|
International Atomic Energy Ag...ency (Contributions to Technical Cooperation Fund Only)
more
|
International Atomic Energy Ag...encyNuclear Security Fund
more
|
|
COVID-19
|
|
6567a38a212eaade2e0f176f
|
2020
|
Canada
|
Global Affairs Canada
|
20202003430007
|
P009105001
|
1
|
Asia, regional
|
Asia
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0.21351
|
0.21351
|
0
|
0
|
0.21351
|
0.21351
|
0
|
0.21351
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
IAEA ASSISTANCE IN INTERNATION...AL COVID-19 RESPONSE/ASSISTANCE A L'AIEA DANS LA RÉPONSE INTERNATIONALE AU COVID-19
more
|
IAEA Assistance in Internation...al COVID-19 Response/Assistance a l'AIEA dans la réponse internationale au COVID-19
more
|
The International Atomic Energ...y Agency (IAEA) will provide diagnostic kits, equipment and training in nuclear-derived detection techniques to countries asking for assistance in tackling the worldwide spread of the novel coronavirus causing COVID-19. The assistance, requested by over 65 countries in Africa, Asia, Latin America and the Caribbean, and Eastern Europe and the Caucasus, is part of intensified global efforts to contain infections. The diagnostic technique, known as real time reverse transcription–polymerase chain reaction (real time RT-PCR), can help detect and identify the novel coronavirus accurately within hours in humans, as well as in animals that may also host it. The IAEA is a member of the World Health Organization (WHO) COVID-19 crisis management team, because the equipment required for this RT-PCR diagnostic procedure relies on nuclear techniques, the IAEA is taking the lead in procuring and delivering these toolkits to requesting countries.
more
|
|
12264
|
COVID-19 control
|
3
|
I.2.b. Basic Health
|
41107
|
International Atomic Energy Ag...ency (Contributions to Technical Cooperation Fund Only)
more
|
International Atomic Energy Ag...encyNuclear Security Fund
more
|
|
COVID-19
|
|
6567a38a212eaade2e0f1770
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20200094340005
|
109434
|
3
|
Brazil
|
South America
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.253504
|
0.060207
|
0
|
0
|
0.253504
|
0.060207
|
0
|
0.253504
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
RAPID, LOW-COST DIAGNOSTICS AN...D DEPLOYABLE SURGE CAPACITY FOR COVID-19
more
|
Rapid, Low-cost Diagnostics an...d Deployable Surge Capacity for COVID-19
more
|
Coronaviruses (CoV) are a larg...e family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Common signs of infection include respiratory symptoms, fever, cough, and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. The novel coronavirus COVID-19 is a new strain that has not been previously associated with humans. The outbreak of COVID-19, first identified in Wuhan (China), highlights the importance of a rapid response to infectious diseases in a highly interconnected world. Innovative diagnostic technologies are key tools in the fight against spread of the COVID-19, allowing frontline responders to quickly triage patients specially in fragile health-care systems. This project will develop tools to provide field-ready, low cost and deployable surge capacity for the diagnosis and surveillance of COVID-19. Moreover, it aims to foster the ability of teams in Vietnam and Brazil to design and manufacture diagnostic tests. The project is led by Dr. Keith Pardee (University of Toronto, Canada) and involves researchers from Canada, USA, Brazil and Vietnam. It was selected for funding through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity which was coordinated by the Canadian Institutes of Health Research (CIHR) in partnership with the International Development Research Centre (IDRC), the Natural Sciences and Engineering Research Council of Canada (NSERC), the Social Sciences and Humanities Research Council (SSHRC), and Genome Canada.
more
|
|
12250
|
Infectious disease control
|
3
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
The Governing Council of the U...niversity of Toronto
more
|
|
COVID-19
|
|
6567a38a212eaade2e0f1771
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20200094340006
|
109434
|
3
|
Brazil
|
South America
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.060207
|
0
|
0
|
0
|
0.060207
|
0
|
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
RAPID, LOW-COST DIAGNOSTICS AN...D DEPLOYABLE SURGE CAPACITY FOR COVID-19
more
|
Rapid, Low-cost Diagnostics an...d Deployable Surge Capacity for COVID-19
more
|
Coronaviruses (CoV) are a larg...e family of viruses that cause illnesses ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Common signs of infection include respiratory symptoms, fever, cough, and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. The novel coronavirus COVID-19 is a strain that has not been previously associated with humans. The outbreak of COVID-19 highlights the importance of a rapid response to infectious diseases in a highly interconnected world. Innovative diagnostic technologies are key tools in the fight against the spread of COVID-19, allowing frontline responders to quickly triage patients, especially in fragile healthcare systems. This project will develop tools to provide field-ready, low-cost, and deployable surge capacity for the diagnosis and surveillance of COVID-19. Moreover, it aims to foster the ability of teams in Vietnam and Brazil to design and manufacture diagnostic tests.This project was selected for funding through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity, coordinated by the Canadian Institutes of Health Research in partnership with IDRC, the Natural Sciences and Engineering Research Council of Canada, the Social Sciences and Humanities Research Council, and Genome Canada.
more
|
|
12250
|
Infectious disease control
|
3
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
The Governing Council of the U...niversity of Toronto
more
|
|
COVID-19
|
|
6567a38a212eaade2e0f1772
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20200094340002
|
109434
|
3
|
Caribbean & Central America, r...egional
more
|
Caribbean & Central America
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.055137
|
0
|
0
|
0
|
0.055137
|
0
|
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
RAPID, LOW-COST DIAGNOSTICS AN...D DEPLOYABLE SURGE CAPACITY FOR COVID-19
more
|
Rapid, Low-cost Diagnostics an...d Deployable Surge Capacity for COVID-19
more
|
Coronaviruses (CoV) are a larg...e family of viruses that cause illnesses ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Common signs of infection include respiratory symptoms, fever, cough, and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. The novel coronavirus COVID-19 is a strain that has not been previously associated with humans. The outbreak of COVID-19 highlights the importance of a rapid response to infectious diseases in a highly interconnected world. Innovative diagnostic technologies are key tools in the fight against the spread of COVID-19, allowing frontline responders to quickly triage patients, especially in fragile healthcare systems. This project will develop tools to provide field-ready, low-cost, and deployable surge capacity for the diagnosis and surveillance of COVID-19. Moreover, it aims to foster the ability of teams in Vietnam and Brazil to design and manufacture diagnostic tests.This project was selected for funding through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity, coordinated by the Canadian Institutes of Health Research in partnership with IDRC, the Natural Sciences and Engineering Research Council of Canada, the Social Sciences and Humanities Research Council, and Genome Canada.
more
|
|
12250
|
Infectious disease control
|
3
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
The Governing Council of the U...niversity of Toronto
more
|
|
COVID-19
|
|
6567a38a212eaade2e0f1773
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20200094340001
|
109434
|
3
|
Caribbean & Central America, r...egional
more
|
Caribbean & Central America
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.232158
|
0.055137
|
0
|
0
|
0.232158
|
0.055137
|
0
|
0.232158
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
RAPID, LOW-COST DIAGNOSTICS AN...D DEPLOYABLE SURGE CAPACITY FOR COVID-19
more
|
Rapid, Low-cost Diagnostics an...d Deployable Surge Capacity for COVID-19
more
|
Coronaviruses (CoV) are a larg...e family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Common signs of infection include respiratory symptoms, fever, cough, and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. The novel coronavirus COVID-19 is a new strain that has not been previously associated with humans. The outbreak of COVID-19, first identified in Wuhan (China), highlights the importance of a rapid response to infectious diseases in a highly interconnected world. Innovative diagnostic technologies are key tools in the fight against spread of the COVID-19, allowing frontline responders to quickly triage patients specially in fragile health-care systems. This project will develop tools to provide field-ready, low cost and deployable surge capacity for the diagnosis and surveillance of COVID-19. Moreover, it aims to foster the ability of teams in Vietnam and Brazil to design and manufacture diagnostic tests. The project is led by Dr. Keith Pardee (University of Toronto, Canada) and involves researchers from Canada, USA, Brazil and Vietnam. It was selected for funding through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity which was coordinated by the Canadian Institutes of Health Research (CIHR) in partnership with the International Development Research Centre (IDRC), the Natural Sciences and Engineering Research Council of Canada (NSERC), the Social Sciences and Humanities Research Council (SSHRC), and Genome Canada.
more
|
|
12250
|
Infectious disease control
|
3
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
The Governing Council of the U...niversity of Toronto
more
|
|
COVID-19
|
|
6567a38b212eaade2e0f1774
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20200094340004
|
109434
|
3
|
Caribbean & Central America, r...egional
more
|
Caribbean & Central America
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.003296
|
0
|
0
|
0
|
0.003296
|
0
|
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
RAPID, LOW-COST DIAGNOSTICS AN...D DEPLOYABLE SURGE CAPACITY FOR COVID-19
more
|
Rapid, Low-cost Diagnostics an...d Deployable Surge Capacity for COVID-19
more
|
Coronaviruses (CoV) are a larg...e family of viruses that cause illnesses ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Common signs of infection include respiratory symptoms, fever, cough, and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. The novel coronavirus COVID-19 is a strain that has not been previously associated with humans. The outbreak of COVID-19 highlights the importance of a rapid response to infectious diseases in a highly interconnected world. Innovative diagnostic technologies are key tools in the fight against the spread of COVID-19, allowing frontline responders to quickly triage patients, especially in fragile healthcare systems. This project will develop tools to provide field-ready, low-cost, and deployable surge capacity for the diagnosis and surveillance of COVID-19. Moreover, it aims to foster the ability of teams in Vietnam and Brazil to design and manufacture diagnostic tests.This project was selected for funding through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity, coordinated by the Canadian Institutes of Health Research in partnership with IDRC, the Natural Sciences and Engineering Research Council of Canada, the Social Sciences and Humanities Research Council, and Genome Canada.
more
|
|
12250
|
Infectious disease control
|
3
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
The Governing Council of the U...niversity of Toronto
more
|
|
COVID-19
|
|
6567a38b212eaade2e0f1775
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20200094340003
|
109434
|
3
|
Caribbean & Central America, r...egional
more
|
Caribbean & Central America
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.013891
|
0.003296
|
0
|
0
|
0.013891
|
0.003296
|
0
|
0.013891
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
RAPID, LOW-COST DIAGNOSTICS AN...D DEPLOYABLE SURGE CAPACITY FOR COVID-19
more
|
Rapid, Low-cost Diagnostics an...d Deployable Surge Capacity for COVID-19
more
|
Coronaviruses (CoV) are a larg...e family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Common signs of infection include respiratory symptoms, fever, cough, and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. The novel coronavirus COVID-19 is a new strain that has not been previously associated with humans. The outbreak of COVID-19, first identified in Wuhan (China), highlights the importance of a rapid response to infectious diseases in a highly interconnected world. Innovative diagnostic technologies are key tools in the fight against spread of the COVID-19, allowing frontline responders to quickly triage patients specially in fragile health-care systems. This project will develop tools to provide field-ready, low cost and deployable surge capacity for the diagnosis and surveillance of COVID-19. Moreover, it aims to foster the ability of teams in Vietnam and Brazil to design and manufacture diagnostic tests. The project is led by Dr. Keith Pardee (University of Toronto, Canada) and involves researchers from Canada, USA, Brazil and Vietnam. It was selected for funding through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity which was coordinated by the Canadian Institutes of Health Research (CIHR) in partnership with the International Development Research Centre (IDRC), the Natural Sciences and Engineering Research Council of Canada (NSERC), the Social Sciences and Humanities Research Council (SSHRC), and Genome Canada.
more
|
|
12250
|
Infectious disease control
|
3
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
The Governing Council of the U...niversity of Toronto
more
|
|
COVID-19
|
|
6567a38b212eaade2e0f1776
|
2020
|
Canada
|
Global Affairs Canada
|
20202010720002
|
P005247002
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
26.170593
|
26.170593
|
0
|
0
|
26.170593
|
26.170593
|
0
|
26.170593
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
COVID-19 RESPONSE MECHANISM/M...CANISME DE RÉPONSE COVID-19
more
|
COVID-19 Response Mechanism/M...canisme de réponse COVID-19
more
|
Canadian funding through this ...project will enable the Global Fund to procure 10 million antigen rapid diagnostic tests (RDTs). These tests represent a significant improvement over existing, lab-based or automated PCR (polymerase chain reaction) tests, which are currently being used in developing countries. Compared with PCR tests, which can be expensive and take longer to provide results, these RDTs are low-cost and can provide results in as little as 15 minutes. Improving access to testing is essential for controlling the spread of COVID-19 as test capacity enables targeted public health measures and use of therapeutics and vaccines as they become available. / Le financement canadien de ce projet permettra au Fonds mondial d'acheter 10 millions de tests de diagnostic rapide des antigènes (TDR). Ces tests représentent une amélioration significative par rapport aux tests RCP (réaction en chaîne de la polymérase) existants, réalisés en laboratoire ou automatisés, qui sont actuellement utilisés dans les pays en développement. Par rapport aux tests RCP, qui peuvent être coûteux et prendre plus de temps pour donner des résultats, ces TDRsont peu coûteux et peuvent donner des résultats en 15 minutes. L'amélioration de l'accès aux tests est essentielle pour contrôler la propagation de la COVID-19 en permettant des mesures de santé publique ciblées et l'utilisation de thérapies et de vaccins dès qu'ils sont disponibles.
more
|
|
12264
|
COVID-19 control
|
1
|
I.2.b. Basic Health
|
47045
|
Global Fund to Fight AIDS, Tub...erculosis and Malaria
more
|
Global Fund to Fight AIDS, Tub...erculosis & Malaria
more
|
|
COVID-19
|
|
6567a38b212eaade2e0f1777
|
2020
|
Canada
|
Global Affairs Canada
|
20202010720001
|
P005247002
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
22.293469
|
22.293469
|
0
|
0
|
22.293469
|
22.293469
|
0
|
22.293469
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
COVID-19 RESPONSE MECHANISM/M...CANISME DE RÉPONSE COVID-19
more
|
COVID-19 Response Mechanism/M...canisme de réponse COVID-19
more
|
Canadian funding through this ...project will enable the Global Fund to procure 10 million antigen rapid diagnostic tests (RDTs). These tests represent a significant improvement over existing, lab-based or automated PCR (polymerase chain reaction) tests, which are currently being used in developing countries. Compared with PCR tests, which can be expensive and take longer to provide results, these RDTs are low-cost and can provide results in as little as 15 minutes. Improving access to testing is essential for controlling the spread of COVID-19 as test capacity enables targeted public health measures and use of therapeutics and vaccines as they become available. / Le financement canadien de ce projet permettra au Fonds mondial d'acheter 10 millions de tests de diagnostic rapide des antigènes (TDR). Ces tests représentent une amélioration significative par rapport aux tests RCP (réaction en chaîne de la polymérase) existants, réalisés en laboratoire ou automatisés, qui sont actuellement utilisés dans les pays en développement. Par rapport aux tests RCP, qui peuvent être coûteux et prendre plus de temps pour donner des résultats, ces TDRsont peu coûteux et peuvent donner des résultats en 15 minutes. L'amélioration de l'accès aux tests est essentielle pour contrôler la propagation de la COVID-19 en permettant des mesures de santé publique ciblées et l'utilisation de thérapies et de vaccins dès qu'ils sont disponibles.
more
|
|
12264
|
COVID-19 control
|
1
|
I.2.b. Basic Health
|
47045
|
Global Fund to Fight AIDS, Tub...erculosis and Malaria
more
|
Global Fund to Fight AIDS, Tub...erculosis & Malaria
more
|
|
COVID-19
|
|
6567a38b212eaade2e0f1778
|
2020
|
Canada
|
Global Affairs Canada
|
20202003430001
|
P009105001
|
1
|
Europe, regional
|
Europe
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0.410081
|
0.410081
|
0
|
0
|
0.410081
|
0.410081
|
0
|
0.410081
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
IAEA ASSISTANCE IN INTERNATION...AL COVID-19 RESPONSE/ASSISTANCE A L'AIEA DANS LA RÉPONSE INTERNATIONALE AU COVID-19
more
|
IAEA Assistance in Internation...al COVID-19 Response/Assistance a l'AIEA dans la réponse internationale au COVID-19
more
|
The International Atomic Energ...y Agency (IAEA) will provide diagnostic kits, equipment and training in nuclear-derived detection techniques to countries asking for assistance in tackling the worldwide spread of the novel coronavirus causing COVID-19. The assistance, requested by over 65 countries in Africa, Asia, Latin America and the Caribbean, and Eastern Europe and the Caucasus, is part of intensified global efforts to contain infections. The diagnostic technique, known as real time reverse transcription–polymerase chain reaction (real time RT-PCR), can help detect and identify the novel coronavirus accurately within hours in humans, as well as in animals that may also host it. The IAEA is a member of the World Health Organization (WHO) COVID-19 crisis management team, because the equipment required for this RT-PCR diagnostic procedure relies on nuclear techniques, the IAEA is taking the lead in procuring and delivering these toolkits to requesting countries.
more
|
|
12264
|
COVID-19 control
|
3
|
I.2.b. Basic Health
|
41107
|
International Atomic Energy Ag...ency (Contributions to Technical Cooperation Fund Only)
more
|
International Atomic Energy Ag...encyNuclear Security Fund
more
|
|
COVID-19
|
|
6567a38b212eaade2e0f1779
|
2020
|
Canada
|
Global Affairs Canada
|
20202005430001
|
P009450001
|
1
|
South Africa
|
South of Sahara
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
1.041433
|
1.041433
|
0
|
0
|
1.041433
|
1.041433
|
0
|
1.041433
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
MOBILE COVID DIAGNOSTIC LABORA...TORIES FOR SOUTH AFRICA/COVID MOBILE DE LABORATOIRES DE DIAGNOSTIC DE L'AFRIQUE DU SUD
more
|
Mobile COVID Diagnostic Labora...tories for South Africa/COVID mobile de laboratoires de diagnostic de l'Afrique du Sud
more
|
This project will support the ...acquisition, installation and certification of the laboratory components for 20 mobile biological units, which will support South Africa with COVID response. / Ce projet permettra de soutenir l'acquisition, l'installation et la certification des composantes de laboratoire pour 20 unités biologique mobile, qui appuiera l'Afrique du Sud avec COVID réponse.
more
|
|
12264
|
COVID-19 control
|
16
|
I.2.b. Basic Health
|
11000
|
Donor Government
|
Canadian Commercial Corporatio...n
more
|
|
COVID-19
|
|
6567a38c212eaade2e0f177a
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20200094340008
|
109434
|
3
|
Viet Nam
|
Far East Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.05844
|
0
|
0
|
0
|
0.05844
|
0
|
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
RAPID, LOW-COST DIAGNOSTICS AN...D DEPLOYABLE SURGE CAPACITY FOR COVID-19
more
|
Rapid, Low-cost Diagnostics an...d Deployable Surge Capacity for COVID-19
more
|
Coronaviruses (CoV) are a larg...e family of viruses that cause illnesses ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Common signs of infection include respiratory symptoms, fever, cough, and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. The novel coronavirus COVID-19 is a strain that has not been previously associated with humans. The outbreak of COVID-19 highlights the importance of a rapid response to infectious diseases in a highly interconnected world. Innovative diagnostic technologies are key tools in the fight against the spread of COVID-19, allowing frontline responders to quickly triage patients, especially in fragile healthcare systems. This project will develop tools to provide field-ready, low-cost, and deployable surge capacity for the diagnosis and surveillance of COVID-19. Moreover, it aims to foster the ability of teams in Vietnam and Brazil to design and manufacture diagnostic tests.This project was selected for funding through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity, coordinated by the Canadian Institutes of Health Research in partnership with IDRC, the Natural Sciences and Engineering Research Council of Canada, the Social Sciences and Humanities Research Council, and Genome Canada.
more
|
|
12250
|
Infectious disease control
|
3
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
The Governing Council of the U...niversity of Toronto
more
|
|
COVID-19
|
|
6567a38c212eaade2e0f177b
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20200094340007
|
109434
|
3
|
Viet Nam
|
Far East Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.246048
|
0.05844
|
0
|
0
|
0.246048
|
0.05844
|
0
|
0.246048
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
RAPID, LOW-COST DIAGNOSTICS AN...D DEPLOYABLE SURGE CAPACITY FOR COVID-19
more
|
Rapid, Low-cost Diagnostics an...d Deployable Surge Capacity for COVID-19
more
|
Coronaviruses (CoV) are a larg...e family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Common signs of infection include respiratory symptoms, fever, cough, and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. The novel coronavirus COVID-19 is a new strain that has not been previously associated with humans. The outbreak of COVID-19, first identified in Wuhan (China), highlights the importance of a rapid response to infectious diseases in a highly interconnected world. Innovative diagnostic technologies are key tools in the fight against spread of the COVID-19, allowing frontline responders to quickly triage patients specially in fragile health-care systems. This project will develop tools to provide field-ready, low cost and deployable surge capacity for the diagnosis and surveillance of COVID-19. Moreover, it aims to foster the ability of teams in Vietnam and Brazil to design and manufacture diagnostic tests. The project is led by Dr. Keith Pardee (University of Toronto, Canada) and involves researchers from Canada, USA, Brazil and Vietnam. It was selected for funding through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity which was coordinated by the Canadian Institutes of Health Research (CIHR) in partnership with the International Development Research Centre (IDRC), the Natural Sciences and Engineering Research Council of Canada (NSERC), the Social Sciences and Humanities Research Council (SSHRC), and Genome Canada.
more
|
|
12250
|
Infectious disease control
|
3
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
The Governing Council of the U...niversity of Toronto
more
|
|
COVID-19
|
|
6567a38c212eaade2e0f177c
|
2020
|
EU Institutions
|
European Commission
|
2019000269004
|
SCR.CTR.415595
|
3
|
South of Sahara, regional
|
South of Sahara
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
10.25641
|
0
|
0
|
0
|
10.25641
|
0
|
0
|
0
|
0
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
P85 - STRENGTHENING LABORATORY... CAPACITIES IN AFRICA AGAINST COVID-19 AND EPIDEMICS: FROM SET UP IN SENEGAL TO SCALE UP IN AFRICA (LABPLUS AFRICA)
more
|
P85 - Strengthening Laboratory... Capacities in Africa Against CoVID-19 and epidemics: from set up in Senegal to scale up in Africa (LABPLUS AFRICA)
more
|
|
|
12264
|
COVID-19 control
|
9,3
|
I.2.b. Basic Health
|
47000
|
Other multilateral institution...s
more
|
Other multilateral institution
|
|
|
|
6567a38c212eaade2e0f177d
|
2020
|
EU Institutions
|
European Commission
|
2020900496038
|
SI2.831412
|
3
|
Sudan
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
2.552707
|
0
|
0
|
0
|
2.552707
|
0
|
0
|
0
|
0
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
STRENGTHENING THE COVID-19 OUT...BREAK RESPONSE IN SUDAN THROUGH SUPPORT TO RAPID RESPONSE TEAMS, CASE DETECTION, CONTACT TRACING AND SUPPORT TO INFECTIO
more
|
Strengthening the Covid-19 out...break response in Sudan through support to rapid response teams, case detection, contact tracing and support to infectio
more
|
Strengthening the Covid-19 out...break response in Sudan through support to rapid response teams, case detection, contact tracing and support to infection prevention and control in health structures in Khartoum state.
more
|
|
72010
|
Material relief assistance and... services
more
|
3,1
|
VIII.1. Emergency Response
|
41307
|
World Health Organisation - as...sessed contributions
more
|
World Health Organisation - as...sessed contributions
more
|
|
|
|
6567a38c212eaade2e0f177e
|
2020
|
EU Institutions
|
European Commission
|
2020900496018
|
SI2.831412
|
3
|
Sudan
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
1.367521
|
0
|
0
|
0
|
1.367521
|
0
|
0
|
0
|
0
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
STRENGTHENING THE COVID-19 OUT...BREAK RESPONSE IN SUDAN THROUGH SUPPORT TO RAPID RESPONSE TEAMS, CASE DETECTION, CONTACT TRACING AND SUPPORT TO INFECTIO
more
|
Strengthening the Covid-19 out...break response in Sudan through support to rapid response teams, case detection, contact tracing and support to infectio
more
|
Strengthening the Covid-19 out...break response in Sudan through support to rapid response teams, case detection, contact tracing and support to infection prevention and control in health structures in Khartoum state.
more
|
|
72010
|
Material relief assistance and... services
more
|
3,1
|
VIII.1. Emergency Response
|
41307
|
World Health Organisation - as...sessed contributions
more
|
World Health Organisation - as...sessed contributions
more
|
|
|
|
6567a38c212eaade2e0f177f
|
2020
|
France
|
Ministry of Foreign Affairs
|
2020060014
|
|
8
|
Chad
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.002507
|
0.002507
|
0
|
0
|
0.002507
|
0.002507
|
|
0.002507
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
DCSD - P105 14. SURCOÛT TESTS... COVID #COVID
more
|
DCSD - P105 14. surcoût tests... COVID #COVID
more
|
DCSD - P105 14. surcoût tests... COVID #COVID - Tchad
more
|
|
12264
|
COVID-19 control
|
16.1
|
I.2.b. Basic Health
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
COVID-19
|
|
6567a38d212eaade2e0f1780
|
2020
|
France
|
Ministry of Foreign Affairs
|
2020064580
|
|
8
|
China (People's Republic of)
|
Far East Asia
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.044944
|
0.044944
|
0
|
0
|
0.044944
|
0.044944
|
|
0.044944
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
CDCS P209 - CHINE (RÉPUBLIQUE... POPULAIRE DE) - SANTÉ DE BASE
more
|
CDCS P209 - Chine (République... populaire de) - Santé de base
more
|
CDCS P209 - Chine (République... populaire de) - Santé de base - Commande de thermomètres destinés à être envoyés en Chine pour la crise du Coronavirus
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
COVID-19
|
|
6567a38d212eaade2e0f1781
|
2020
|
France
|
Ministry of Foreign Affairs
|
2020064577
|
|
8
|
China (People's Republic of)
|
Far East Asia
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.009197
|
0.009197
|
0
|
0
|
0.009197
|
0.009197
|
|
0.009197
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
CDCS P209 - CHINE (RÉPUBLIQUE... POPULAIRE DE) - SANTÉ DE BASE
more
|
CDCS P209 - Chine (République... populaire de) - Santé de base
more
|
CDCS P209 - Chine (République... populaire de) - Santé de base - Commande de thermomètres destinés à être envoyés en Chine pour la crise du Coronavirus
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
COVID-19
|
|
6567a38d212eaade2e0f1782
|
2020
|
France
|
Ministry of Foreign Affairs
|
2020065436
|
|
8
|
Congo
|
South of Sahara
|
LMICs
|
ODA Grants
|
8
|
10
|
110
|
C01
|
0.068376
|
0.068376
|
0
|
0
|
0.068376
|
0.068376
|
|
0.068376
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
P209 - OBJECTIFS DE DÉVELOPPE...MENT DURABLE (P 209) - SANTE
more
|
P209 - Objectifs de développe...ment durable (P 209) - SANTE
more
|
P209 - Objectifs de développe...ment durable (P 209) - SANTE - Surveillance de l'infection au sein du personnel de santé impliqué dans les structures de santé accueillant des patients COVID-19 à Brazzaville - L'objectif général de l'étude est d'évaluer la proportion de personnes infectées par SRAS-COV-2 dans le personnel soignant et le traiter immédiatement afin de réduire la transmission en milieu hospitalier au Congo-Brazzaville.
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
21000
|
International NGO
|
ONG INTERNATIONALE
|
|
COVID-19
|
|
6567a38d212eaade2e0f1783
|
2020
|
France
|
Ministry of Foreign Affairs
|
2020060006
|
|
8
|
Gabon
|
South of Sahara
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.070655
|
0.070655
|
0
|
0
|
0.070655
|
0.070655
|
|
0.070655
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
DCSD - P105 KITS DÉPISTAGE E...T FINANCEMENT SURCOUT COVID #COVID
more
|
DCSD - P105 Kits dépistage e...t financement surcout COVID #COVID
more
|
DCSD - P105 Kits dépistage e...t financement surcout COVID #COVID - Gabon
more
|
|
12264
|
COVID-19 control
|
16.1
|
I.2.b. Basic Health
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
COVID-19
|
|
6567a38d212eaade2e0f1784
|
2020
|
France
|
French Development Agency
|
2020144000
|
CGN121102
|
1
|
Guinea
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
1.139601
|
1.139601
|
0
|
0
|
1.139601
|
1.139601
|
0
|
1.139601
|
0
|
0
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
CV19HICT - PROJET D'APPUI AU R...ENFORCEMENT DES LABORATOIRES D'ANALYSES MÉDICALES DU SYSTÈME DE SANTÉ GUINÉEN
more
|
CV19HICT - Projet d'appui au r...enforcement des laboratoires d'analyses médicales du système de santé guinéen
more
|
L'objectif du projet est d'am...liorer les capacités de diagnostic du système de santé guinéen sur le territoire national. Il permettra, en synergie avec les projets des autres PTF de Guinée, d'accompagner la mise en œuvre de la politique nationale de biologie médicale, à travers (1) l'amélioration du cadre institutionnel . (2) l'amélioration des conditions d'exercice de la biologie médicale . (3) la professionnalisation de la gestion des laboratoires. [Muskoka,SMI,MDV,ASE]http://www.afd.fr/base-projets/consulterProjet.action?idProjet=CGN1211
more
|
|
12250
|
Infectious disease control
|
3
|
I.2.b. Basic Health
|
12001
|
Central Government
|
|
|
COVID-19
|
|
6567a38d212eaade2e0f1785
|
2020
|
France
|
Ministry of Foreign Affairs
|
2020064620
|
|
8
|
Lebanon
|
Middle East
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.023339
|
0.023339
|
0
|
0
|
0.023339
|
0.023339
|
|
0.023339
|
|
|
COVID-19
|
COVID-19 Diagnostics
|
100
|
CDCS P209 - LIBAN - SANTÉ DE ...BASE
more
|
CDCS P209 - Liban - Santé de ...base
more
|
CDCS P209 - Liban - Santé de ...base - Commande 1 de 4 appareils Vita PCR pour le Liban.
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
|
